Critique Pembrolizumab (Keytruda): CADTH Reimbursement Recommendation: Indication: Together with chemotherapy, with the cure of adult patients with regionally recurrent unresectable or metastatic triple-damaging breast most cancers who may have not acquired prior chemotherapy for metastatic sickness and whose tumours Convey programmed mobile Loss o… Read More